The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF)

Psychopharmacology Bulletin

Volumn 32, Issue 1, 1996, Pages 111-121

  Chengappa, K N Roy ^a,b   Gopalani, Aziz ^a   Haught, Marcia K ^c   McChesney, Kathy ^c   Baker, Robert W ^a,b   Schooler, Nina R ^b  

^a Mayview State Hospital   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c HMI Pharmaceutical Services   (United States)

Author keywords

agranulocytosis; clozapine; granulocyte colony stimulating factor

Indexed keywords

CLOZAPINE; RANITIDINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; AGRANULOCYTOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; AGRANULOCYTOSIS; CLOZAPINE; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0029990612     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Alphs, LD, and Lee, HS. Comparison of withdrawal of typical and atypical antipsychotic drugs: A case study. J. Clin. Psychiatry 52:346-348, 1991.
2. Alvir, JMJ, and Lieberman, JA. A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experience. J. Clin. Psychopharmacol. 14:87-89, 1994.
3. Alvir, JMJ; Lieberman, JA; Safferman, AZ; Schwimmer, JL; and Schaaf JA. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N. Engl. J. Med. 329:162-167, 1993.
4. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3d ed., revised. Washington, DC: The Association, 1987.
5. Andermann, B, and Griffith, RW. Clozapine-induced agranulocytosis: A situation report up to August 1976. Eur. J. Clin. Pharmacol. 11:199-201, 1977.
6. Barnas, C; Zwierzina, H; Hummer, M; Sperner-Unterweger, B; Stern, A; and Fleischhacker, WW. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: A case report. J. Clin. Psychiatry 53:245-247, 1992.
7. Borrison, RL; Diamond, BI; Sinha, D; Gupta, RL; and Ajiboye, PA. Clozapine withdrawal rebound psychosis. Psychopharmacol. Bull. 24:260-263, 1988.
8. Bradford, CR; Ong, ELC; Hendrick, DJ; and Saunders, PWG. Use of colony stimulating factors for the treatment of druginduced agranulocytosis. Br. J. Haematol. 84:182-183, 1993.
9. Brenner, LO. Agranulocytosis and ranitidine (Letter). Ann. Intern. Med. 104:896-897, 1986.
10. Cappellari, G; Gaio, A; Cavallaro, A: Cardaioli, C; Simioni, L; La Valle, R; and Agostini, C. Use of colony stimulating factors for the treatment of drug-induced agranulocytosis. Br. J. Haematol. 84:183-184, 1993.
11. Ekblom, B; Eriksson, K; and Lindstrom, LH. Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology 83:293-294, 1984.
12. Geibig, CB, and Marks, LW. Treatment of clozapine and molindone-induced agranulocytosis with granulocyte colony-stimulating factor. Ann. Pharmacother. 27:1190-1192, 1993.
13. Gerson, SL. Clozapine - Deciphering the risks (Editorial). N. Engl. J. Med. 329:204-205, 1993.
14. Gerson, SL. G-CSF and the management of clozapine-induced agranulocytosis. J. Clin. Psychiatry 55(Suppl. B):139-142, 1994.
15. Gerson, SL; Gullion, G; Yeh, HS; and Masor, H. Granulocyte colony-stimulating factor for clozapine-induced agranulocytosis. Lancet 340:1097, 1992.
16. Gerson, SL; Lieberman, JA; Friedenberg, WR; Lee, D; Marx, JJ; and Meltzer, H. Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet 338:262-263, 1991.
17. Gerson, SL, and Meltzer, H. Mechanisms of clozapine-induced agranulocytosis. Drug Safety 7(Suppl. 1):17-25, 1992.
18. Gullion, G, and Yeh, HS. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte-colony stimulating factor. J. Clin. Psychiatry 55:401-405, 1994.
19. Idanpaan-Heikkila, J; Alhava, E; Olkinuora, M; and Palva, IP. Agranulocytosis during treatment with clozapine. Eur. J. Clin. Pharmacol. 11:193-198, 1977.
20. Junghan, U; Albers, M; and Woggon, B. Increased risk of hematological side-effects in psychiatric patients treated with clozapine and carbamazepine. Pharmacopsychiatry 26:262, 1993.
21. Kando, JC; Tohen, M; Castillo, J; and Centorrino, F. Concurrent use of clozapine and valproate in affective and psychotic disorders. J. Clin. Psychiatry 55:255-257, 1994.
22. Krupp, P, and Barnes, P. Leponex-associated granulocytopenia: A review of the situation. Psychopharmacology 99 (Suppl.):S118-S121, 1989.
23. Lamberti, JS; Bellnier, T; Schwarzkopf, SB; and Schneider, E. Filgrastim treatment of three patients with clozapine-induced agranulocytosis. J. Clin. Psychiatry 56:256-259, 1995.
24. Lane, GP, and Speed, B. Agranulocytosis after ranitidine administration. Med. J. Aust. 150:595-596, 1989.
25. Lieberman, JA; Johns, CA; Kane, JM; Rai, K; Pisciotta, AV; Saltz, BL; and Howard, A. Clozapine-induced agranulocytosis: Non-cross-reactivity with other psychotropic drugs. J. Clin. Psychiatry 49:271-277, 1988.
26. Lieberman, JA; Kane, JM; and Johns, CA. Clozapine: Guidelines for clinical management. J. Clin. Psychiatry 50:329-338, 1989.
27. Lindstrom, LH. The effect of long-term treatment with clozapine in schizophrenia: A retrospective study in 96 schizophrenics treated with clozapine for up to 13 years. Acta. Psychiatr. Scand. 77:524-529, 1988.
28. Marder, SR, and Van Putten, T. Who should receive clozapine? Arch. Gen. Psychiatry 45:865-867, 1988.
29. Nielson, H. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment of clozapine-induced agranulocytosis. J. Intern. Med. 234:529-531, 1993.
30. Oren, R; Granat, E; Shtrussberg, S; and Matzner, Y. Clozapine-induced agranulocytosis treated with granulocyte macrophage colony stimulating factor. Br. J. Psychiatry 162:686-687, 1993.
31. Patton, WP; Holyoake, TL; Yates, JM; Boughton, BJ; and Franklin, IM. Accelerated recovery from drug-induced agranulocytosis following G-CSF therapy. Br. J. Haematol. 80:564-565, 1992.
32. Patton, WN. Use of colony stimulating factors in the treatment of drug-induced agranulocytosis. Br. J. Haematol. 84:184-185, 1993.
33. Peacock, L, and Gerlach, J. Clozapine treatment in Denmark: Concomitant psychotropic medication and hematological monitoring in a system with liberal usage practices. J. Clin. Psychiatry 55:44-49, 1994.
34. Physician's Desk Reference - PDR. 48th ed. Montvale, NJ: Medical Economics Data Production Company, 1994.
35. Pisciotta, AV; Konings, SA; Ciesmier, LL; Cronkite, CE; and Lieberman, JA. On the possible mechanisms and predictability of clozapine-induced agranulocytosis. Drug Safety 7(Suppl. 1):33-44, 1992.
36. Raison, CL; Guze, BH; and Kissell, RI. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor. J. Clin. Psychopharmacol. 14:285-286, 1994.
37. Ryabik, BM; Nguyen, VT; Mann, RM; Smith, JD; and Lippmann, SB. Clozapine-induced agranulocytosis and colony stimulating cytokines. Gen. Hosp. Psychiatry 15:263-265, 1993.
38. Safferman, AZ; Lieberman, JA; Alvir, JMJ; and Howard, A. Rechallenge in clozapine-induced agranulocytosis. Lancet 339:1296-1297, 1992.
39. Salzman, C. Mandatory monitoring for side effects: The "bundling" of clozapine. N. Engl. J. Med. 323:827-829, 1990.
40. Shields, LI; Files, JA; Doll, DC; and Greenburg, BR. Ranitidine and agranulocytosis (Letter). Ann. Intern. Med. 104:128, 1986.
41. Valevski, A; Modai, I; Lahav, M; and Weizman, A. Clozapinelithium combined treatment and agranulocytosis. Int. Clin. Psychopharmacol. 8:63-65, 1993.
42. Watts, RG; Emanuel, PD; Zuckerman, KS; and Howard, TH. Valproic acid-induced cytopenias: Evidence for a doserelated suppression of hematopoiesis. J. Pediatr. 117:495-499, 1990.
43. Weide, R; Koppler, H; Heymanns, J; Pfluger, KH; and Havemann, K. Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF). Br. J. Haematol. 80:557-559, 1992.